Privacy Statement   Terms & Conditions   Sitemap  
  Diseases   Research   About us  
Facts & Figures News Career Baxter Worldwide
 
Press Releases

  Baxter initiates clinical study with cell-based candidate H5N1 Pandemic Vaccine

Deerfield, Ill., July 5, 2006 Baxter International Inc. (NYSE: BAX) today announced that it has initiated a Phase I/II clinical trial to tes ...

Date: 2006/07/11 » read more

  Baxter to participate in development of cell-based vaccines for U.S. Department of Health and Human Services

DEERFIELD, Ill., May 4, 2006
Baxter International Inc. (NYSE:BAX) today announced that it is collaborating with DVC LLC, a Computer Scienc ...

Date: 2006/05/07 » read more

  Baxter Receives Contract From National Health Service in United Kingdom to Produce Stockpile of H5N1 Flu Vaccine

DEERFIELD, Ill. and LONDON, UK, February 24, 2006
Baxter International Inc. (NYSE:BAX) announced today that its European subsidiary has re ...

Date: 2006/02/28 » read more

  Vaccination Schedule

Date: 2006/02/07 » read more

  Acambis submits US licence application for ACAM2000 smallpox vaccine

Cambridge, UK and Cambridge, Massachusetts – 18 January 2006 – Acambis plc (Acambis) (LSE: ACM, NASDAQ: ACAM) announces that it has submitted t ...

Date: 2006/01/27 » read more

  Acambis completes delivery of 500,000 doses of MVA3000 smallpox vaccine to US Government

Cambridge, UK and Cambridge, Massachusetts – 2 December 2005 – Acambis plc (Acambis) (LSE: ACM, NASDAQ: ACAM) announces that it has completed the deli ...

Date: 2005/12/02 » read more

  Acambis announces start of MVA3000 Phase ll trial

Cambridge, UK and Cambridge, Massachusetts – 14 July 2005 – Acambis plc (“Acambis”) (LSE: ACM, NASDAQ: ACAM) today announces that it has comme ...

Date: 2005/07/27 » read more

  CSC Wins $19.6 Million Contract for Advanced Development of Chemical Nerve Agent Treatment

CSC’s DVC Teams with Baxter Healthcare Corporation to Produce Plasma-Derived Human Butyrylcholinesterase EL SEGUNDO, Calif. and DEERFIELD, ...

Date: 2005/04/13 » read more

  Baxter Satellite Symposium

Meningococcal Disease - PREVALENCE AND PREVENTION.
4th World Congress of The World Society for Pediatric Infectious Diseases Wars ...

Date: 2005/01/01 » read more

  Baxter Satellite Symposium

2nd European Influenza Conference St.Julians, Malta September 11-14, 2005

Date: 2005/01/01 » read more

 
« previous   1 | 2 | 3   next »
 
 
  » find


 

Baxter initiates clinical study with cell-based candidate H5N1 Pandemic Vaccine
» read more

Baxter to participate in development of cell-based vaccines for U.S. Department of Health and Human Services
» read more

Baxter Receives Contract From National Health Service in United Kingdom to Produce Stockpile of H5N1 Flu Vaccine
» read more

 
Baxter Vaccines Industriestrasse 67, A-1221 Wien, Tel: +43-1-20100,